B. Metzler seel. Sohn & Co. AG Purchases 18,042 Shares of MetLife, Inc. $MET

B. Metzler seel. Sohn & Co. AG raised its position in MetLife, Inc. (NYSE:MET) by 39.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 63,296 shares of the financial services provider’s stock after buying an additional 18,042 shares during the period. B. Metzler seel. Sohn & Co. AG’s holdings in MetLife were worth $5,214,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Foster Dykema Cabot & Partners LLC purchased a new stake in shares of MetLife during the third quarter valued at approximately $32,000. Evolution Wealth Management Inc. purchased a new position in MetLife in the second quarter worth $35,000. Salomon & Ludwin LLC grew its stake in MetLife by 95.4% in the 3rd quarter. Salomon & Ludwin LLC now owns 422 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 206 shares during the period. True Wealth Design LLC grew its stake in MetLife by 564.1% in the 3rd quarter. True Wealth Design LLC now owns 425 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 361 shares during the period. Finally, MTM Investment Management LLC purchased a new stake in shares of MetLife during the 2nd quarter valued at $37,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife Stock Performance

NYSE:MET opened at $71.83 on Monday. The business’s fifty day moving average is $77.20 and its 200 day moving average is $78.72. The firm has a market cap of $46.84 billion, a price-to-earnings ratio of 15.28, a PEG ratio of 0.66 and a beta of 0.76. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.20 and a current ratio of 0.20. MetLife, Inc. has a 52-week low of $65.21 and a 52-week high of $85.00.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 EPS for the quarter, topping the consensus estimate of $2.34 by $0.15. MetLife had a return on equity of 21.81% and a net margin of 4.38%.The business had revenue of $52.44 billion during the quarter, compared to the consensus estimate of $31.43 billion. During the same quarter last year, the company earned $2.08 EPS. The firm’s revenue was up 27.6% compared to the same quarter last year. Research analysts predict that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Stockholders of record on Tuesday, February 3rd will be given a $0.5675 dividend. This represents a $2.27 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date is Tuesday, February 3rd. MetLife’s dividend payout ratio (DPR) is 48.30%.

Analysts Set New Price Targets

MET has been the topic of a number of recent analyst reports. Mizuho set a $100.00 price target on shares of MetLife in a report on Thursday, February 12th. Barclays set a $90.00 price objective on shares of MetLife in a report on Thursday, January 8th. Keefe, Bruyette & Woods lowered their price objective on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 11th. Evercore set a $95.00 target price on shares of MetLife in a research note on Tuesday, February 10th. Finally, Morgan Stanley reduced their target price on shares of MetLife from $101.00 to $93.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Two research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $94.18.

Trending Headlines about MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife confirmed its previously announced Q1 2026 dividend on its Series A floating-rate preferred shares, $0.31501229 per share, signaling consistency in capital returns for preferred holders and helping support yield-sensitive investors. Article Title
• Positive Sentiment: MetLife and partner Crow Holdings completed the sale/trade of 210 multifamily units in Tampa — an example of active portfolio management that can free capital or crystallize gains from real-estate holdings. Article Title
• Neutral Sentiment: MetLife GCC leased ~75,000 sq ft in Noida’s Oxygen Business Park — a regional expansion/lease that speaks to business presence in India but is unlikely to move the stock materially in the near term. Article Title
• Neutral Sentiment: High-profile events at MetLife Stadium (temporary renaming/World Cup hosting coverage, ticket guides) increase brand visibility and venue revenue potential, but these items are peripheral to core insurance fundamentals. Article Title
• Neutral Sentiment: A recent piece comparing MetLife’s stock performance to peers provides context for relative valuation and momentum; useful for investors but not a direct catalyst. Article Title
• Negative Sentiment: Morgan Stanley published a pessimistic forecast for MET, which likely contributed to selling pressure and the intraday decline — analyst downgrades/price-target cuts are common drivers of short-term stock weakness. Article Title

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.